Actually, synthetic calpain inhibitors improved memory and synaptic transmission in a mouse model of Alzheimer disease, and specific calpain inhibition by calpastatin prevented neurodegeneration and restored normal lifespan in tau P301L mice, possibly by limiting the toxic forms of tau18, 19. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.